ES2172141T3 - Nuevo procedimiento para la preparacion de una sustancia farmacologicamente activa. - Google Patents

Nuevo procedimiento para la preparacion de una sustancia farmacologicamente activa.

Info

Publication number
ES2172141T3
ES2172141T3 ES98921670T ES98921670T ES2172141T3 ES 2172141 T3 ES2172141 T3 ES 2172141T3 ES 98921670 T ES98921670 T ES 98921670T ES 98921670 T ES98921670 T ES 98921670T ES 2172141 T3 ES2172141 T3 ES 2172141T3
Authority
ES
Spain
Prior art keywords
preparation
pharmacologically active
active substance
new procedure
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98921670T
Other languages
English (en)
Inventor
Maria Bakonyi
Nagy Marianna Csatarine
Leventene Molnar
Antal Gajary
Edit Alattyani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of ES2172141T3 publication Critical patent/ES2172141T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se presenta un proceso para la preparación de metil-[2(2-tienil)-etilamino]-(2-halogenofenil)-acetatos de la fórmula general (VI) comenzando a partir de acetamidas de la fórmula general (VII). Existen ingredientes farmacológicamente activos de gran valor de efecto antitrombótico entre los compuestos de la fórmula general (VI).
ES98921670T 1997-05-13 1998-05-11 Nuevo procedimiento para la preparacion de una sustancia farmacologicamente activa. Expired - Lifetime ES2172141T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700885A HU222283B1 (hu) 1997-05-13 1997-05-13 Eljárás tieno[3,2-c]piridin-származékok előállítására

Publications (1)

Publication Number Publication Date
ES2172141T3 true ES2172141T3 (es) 2002-09-16

Family

ID=90014236

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98921670T Expired - Lifetime ES2172141T3 (es) 1997-05-13 1998-05-11 Nuevo procedimiento para la preparacion de una sustancia farmacologicamente activa.

Country Status (38)

Country Link
US (1) US6180793B1 (es)
EP (1) EP0981529B1 (es)
KR (1) KR100428238B1 (es)
CN (1) CN1109036C (es)
AR (1) AR014349A1 (es)
AT (1) ATE212025T1 (es)
AU (1) AU735702B2 (es)
BR (1) BR9809112B1 (es)
CA (1) CA2289623C (es)
CO (1) CO4950564A1 (es)
CZ (1) CZ292820B6 (es)
DE (1) DE69803176T2 (es)
DK (1) DK0981529T3 (es)
DZ (1) DZ2487A1 (es)
EE (1) EE03925B1 (es)
EG (1) EG21973A (es)
ES (1) ES2172141T3 (es)
HK (1) HK1027350A1 (es)
HR (1) HRP980240B1 (es)
HU (1) HU222283B1 (es)
ID (1) ID23018A (es)
IL (1) IL132774A0 (es)
IS (1) IS1883B (es)
ME (1) ME01636B (es)
MY (1) MY121299A (es)
NO (1) NO325419B1 (es)
NZ (1) NZ501577A (es)
PL (1) PL194859B1 (es)
PT (1) PT981529E (es)
RS (1) RS49626B (es)
RU (1) RU2172315C1 (es)
SA (1) SA98190583B1 (es)
SK (1) SK283700B6 (es)
TR (1) TR199902783T2 (es)
TW (1) TW552263B (es)
UA (1) UA66359C2 (es)
WO (1) WO1998051689A1 (es)
ZA (1) ZA983921B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
HU226421B1 (en) 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
IN191030B (es) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
AU2003238664A1 (en) 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
DE602004025267D1 (de) 2003-11-03 2010-03-11 Cadila Healthcare Ltd Verfahren zur herstellung form i von (s)-(+)- clopidogrelbisulfat
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
MX2007010267A (es) * 2005-02-24 2007-09-11 Teva Pharma Base de clopidogrel adecuada para formulacion farmaceutica y preparacion de ella.
KR100681512B1 (ko) 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
CN102014899A (zh) * 2006-04-27 2011-04-13 因-斯韦特实验室有限公司 硫酸氢氯吡格雷多晶型物的制备方法
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
US8247558B2 (en) 2006-09-04 2012-08-21 Ranbaxy Laboratories Limited Process for the preparation of clopidogrel and its pharmaceutically acceptable salts
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
CN102186858A (zh) * 2008-10-24 2011-09-14 桑多斯股份公司 制备s-氯吡格雷的方法
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101544655B (zh) * 2009-05-05 2012-07-04 上海医药集团股份有限公司 噻吩并[3，2-c]吡啶衍生物的制备方法
CN101863899B (zh) * 2010-06-21 2013-03-20 常州制药厂有限公司 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法
KR20170004283A (ko) 2015-07-02 2017-01-11 류종렬 그립부가 개선된 쉐이크 핸드형 탁구 라켓
KR20170004282A (ko) 2015-07-02 2017-01-11 류종렬 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
DE69803176T2 (de) 2002-08-22
PT981529E (pt) 2002-06-28
CZ393999A3 (cs) 2000-04-12
CN1255924A (zh) 2000-06-07
ATE212025T1 (de) 2002-02-15
IS5244A (is) 1999-11-11
KR20010012511A (ko) 2001-02-15
PL336693A1 (en) 2000-07-03
EE9900488A (et) 2000-06-15
CN1109036C (zh) 2003-05-21
JP2001525819A (ja) 2001-12-11
SK283700B6 (sk) 2003-12-02
ZA983921B (en) 1998-11-09
IL132774A0 (en) 2001-03-19
WO1998051689A1 (en) 1998-11-19
RS49626B (sr) 2007-08-03
RU2172315C1 (ru) 2001-08-20
NO325419B1 (no) 2008-04-21
EP0981529A1 (en) 2000-03-01
ME01636B (me) 2007-08-03
PL194859B1 (pl) 2007-07-31
US6180793B1 (en) 2001-01-30
EG21973A (en) 2002-05-31
NZ501577A (en) 2001-10-26
KR100428238B1 (ko) 2004-04-30
HUP9700885A2 (hu) 1999-09-28
TW552263B (en) 2003-09-11
EE03925B1 (et) 2002-12-16
CO4950564A1 (es) 2000-09-01
SK151699A3 (en) 2000-07-11
HUP9700885D0 (en) 1997-07-28
TR199902783T2 (xx) 2000-04-21
NO995533D0 (no) 1999-11-12
UA66359C2 (uk) 2004-05-17
MY121299A (en) 2006-01-28
HU222283B1 (hu) 2003-05-28
AU7444898A (en) 1998-12-08
DE69803176D1 (de) 2002-02-21
HK1027350A1 (en) 2001-01-12
HRP980240A2 (en) 1999-02-28
EP0981529B1 (en) 2002-01-16
HUP9700885A3 (en) 2000-06-28
AU735702B2 (en) 2001-07-12
CA2289623C (en) 2007-01-30
DK0981529T3 (da) 2002-04-22
NO995533L (no) 1999-12-13
JP4256478B2 (ja) 2009-04-22
IS1883B (is) 2003-08-15
HRP980240B1 (en) 2003-02-28
BR9809112A (pt) 2000-08-01
CA2289623A1 (en) 1998-11-19
CZ292820B6 (cs) 2003-12-17
SA98190583B1 (ar) 2006-08-19
BR9809112B1 (pt) 2010-10-05
AR014349A1 (es) 2001-02-28
ID23018A (id) 1999-12-30
DZ2487A1 (fr) 2004-07-30
YU58799A (sh) 2002-06-19

Similar Documents

Publication Publication Date Title
ES2172141T3 (es) Nuevo procedimiento para la preparacion de una sustancia farmacologicamente activa.
ES2195335T3 (es) Nuevos productos intermedios y procedimiento para la preparacion de los mismos.
DZ2640A1 (fr) Composés thérapeutiquement actifs contenant de l'indazole en remplacement bio-isostérique du catéchol leur préparation et composition pharmaceutique les contenant.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
FI872379A (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
CA2244785A1 (en) Pentafluorobenzenesulfonamides and analogs
MC2091A1 (fr) Procedes pour la preparation de composes a action anti-inflammatoire et de formulations pharmaceutiques les contenant
ID20915A (id) Cincin heterosiklis baru yang beranggotakan 5, pembuatannya, penggunaannya dan pembuatan bahan farmasi yang terdiri dari cincin heterosiklis baru tersebut
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
BR9812120A (pt) Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação
TNSN97156A1 (fr) Derives de pyrrolidinyl-et pyrrolinyl-ethylamine, procede pour leur preparation et compositions pharmaceutiques les contenant
EA199900812A1 (ru) Производные циклопентенона
NO168428C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat
ITMI942362A0 (it) Procedimento per la preparazione di una combinazione chimica farmacologicamente attiva
ATE239739T1 (de) Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
GB9420747D0 (en) 1,5 benzodiazepine derivatives
MX9603568A (es) Derivados de la alquenil-benzoilguanidina.
RU93047049A (ru) Новые производные фосфолипидов
ES2178080T3 (es) Procedimiento para la preparacion de derivados de alcoxi-o ariloxi-pirazina.
ES2122387T3 (es) Procedimiento para la preparacion de la forma 1 del clorhidrato de ranitidina.
NO20014889D0 (no) Fremgangsmåte for fremstilling av medisinske midler
AU1405988A (en) Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing them
EA200100107A1 (ru) Новые 2,3,3a,4,9,9a-гексагидро-8-гидрокси-1h-бенз[f]индолы, способ их получения и их применение в качестве лекарственных средств

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 981529

Country of ref document: ES